The largest database of trusted experimental protocols

Basiliximab

Manufactured by Absolute Antibody

Basiliximab is a monoclonal antibody product used in the laboratory setting for research purposes. It functions as an interleukin-2 receptor antagonist.

Automatically generated - may contain errors

2 protocols using basiliximab

1

Quantifying IL-2 Signaling Blockade

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pan T cells were isolated from splenocytes using the Dynabeads FlowComp™ Mouse Pan T (CD90.2) kit. 200,000 mouse T cells and human PBMC, in complete RPMI were plated and rested for 2-3 hours at 37°C. Antibodies (mouse: αCD25PC61 or anti CD25NIB (both mIgG2a), αIL-2 neutralizing antibody (nAb) (JES6-1A12, BioXcell); human: RG6292, human IgG1 isotype control, Basiliximab (Absolute Antibody), Daclizumab (Absolute Antibody)) were added at 50 μg/ml (mouse) and 10 μg/ml (human), respectively, and were incubated with the cells for 30 mins at 37°C, following which cells were stimulated with IL-2 (50U/ml (mouse) and 10 U/ml (human) respectively, both Peprotech) for 10 mins at 37°C. IL-2 induced STAT5 phosphorylation was stopped when the cells were fixed and permeabilized with the eBioscience™ FoxP3 / Transcription Factor Staining Buffer Set and treated with the BD Phosflow Perm Buffer III. Blocking was calculated as follows: % blocking = 100 x [(% Stat5+ cells No Ab group - % Stat5+ cells 50ug/ml Ab group) / (% Stat5+ cells No Ab group)].
+ Open protocol
+ Expand
2

Quantifying IL-2 Signaling Blockade

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pan T cells were isolated from splenocytes using the Dynabeads FlowComp™ Mouse Pan T (CD90.2) kit. 200,000 mouse T cells and human PBMC, in complete RPMI were plated and rested for 2-3 hours at 37°C. Antibodies (mouse: αCD25PC61 or anti CD25NIB (both mIgG2a), αIL-2 neutralizing antibody (nAb) (JES6-1A12, BioXcell); human: RG6292, human IgG1 isotype control, Basiliximab (Absolute Antibody), Daclizumab (Absolute Antibody)) were added at 50 μg/ml (mouse) and 10 μg/ml (human), respectively, and were incubated with the cells for 30 mins at 37°C, following which cells were stimulated with IL-2 (50U/ml (mouse) and 10 U/ml (human) respectively, both Peprotech) for 10 mins at 37°C. IL-2 induced STAT5 phosphorylation was stopped when the cells were fixed and permeabilized with the eBioscience™ FoxP3 / Transcription Factor Staining Buffer Set and treated with the BD Phosflow Perm Buffer III. Blocking was calculated as follows: % blocking = 100 x [(% Stat5+ cells No Ab group - % Stat5+ cells 50ug/ml Ab group) / (% Stat5+ cells No Ab group)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!